DPP IV inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S374000, C546S274100, C548S236000

Reexamination Certificate

active

06861440

ABSTRACT:
The present invention relates to compounds of formula (I)wherein R1, R2, and X are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with DPP IV, such as diabetes, particularly non-insulin dependent diabetes mellitus, and impaired glucose tolerance.

REFERENCES:
patent: 5455351 (1995-10-01), Kempf et al.
patent: 6011115 (2000-01-01), Miharu et al.
patent: 6110949 (2000-08-01), Villhauer
patent: 6124305 (2000-09-01), Villhauer
patent: 19616486 (1997-10-01), None
patent: 19616486 (1997-10-01), None
patent: 19834591 (2000-02-01), None
patent: WO 9501976 (1995-01-01), None
patent: WO 9610018 (1996-04-01), None
patent: WO 9819998 (1998-05-01), None
patent: WO 9938501 (1999-08-01), None
patent: WO 9938501 (1999-08-01), None
patent: WO 0008002 (2000-02-01), None
patent: WO 0034241 (2000-06-01), None
patent: WO 0119805 (2001-03-01), None
patent: WO 0134594 (2001-05-01), None
patent: WO 0140180 (2001-06-01), None
patent: WO 0155105 (2001-08-01), None
patent: WO 0162266 (2001-08-01), None
patent: WO 0230890 (2002-04-01), None
Schunack et al., Z. Naturforschung, 42b, pp. 238-242 (1987).
Lipp et al., Eur. J. Med. Chem., 30, pp. 219-225 (1995).
Horne et al., Heterocycles, 39, pp. 139-153, (1994).
Francis et al., Tetrahedron Letters, 28, pp. 5133-5136 (1987).
Ali et al., Pak. J. Sci. Ind. Res., 36, pp. 502-510 (1993).
Weintraub, P.M., J. Med. Chem, 15, pp. 419-420 (1972).
Goto et al., Chem. Pharm. Bull., 19, pp. 2050-2057 (1971).
Golfier et al., J. Heterocycl. Chem., 10, pp. 989-991 (1973).
Singh et al., Ind. J. Chem., 22B, pp. 1177-1178 (1983).
Carrera et al., Synlett, 1, p. 93-94 (1994).
Agarwal et al., Synth. Commun., 23, pp. 1101-1110 (1993).
Qizhuang et al., J. Med. Chem., 32, pp. 478-486 (1989).
Freedman et al., J. Heterocycl. Chem., 27, pp. 343-346 (1990).
Collins et al., J. Med. Chem., 41, pp. 5037-5054 (1998).
Novartis AG, Expert Opinion on Therapeutic Patents, Ashley Publications, GB, vol. 10, No. 12, pp. 1937-1942 (2000).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

DPP IV inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with DPP IV inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DPP IV inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3370598

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.